|
SupraxDrug - Suprax The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Cefixime
Strength -
200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Applicant -
LEDERLE
New Drug Application (NDA) Number -
050621
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Apr 28, 1989
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Lederle Laboratories Div American Cyanamid Co
Suprax
Omnicef 300mg Capsule; Oral
Omnicef 125mg/5ml For Suspension; Oral Omnicef 250mg/5ml For Suspension; Oral Spectracef 200mg Tablet; Oral Maxipime Eq 1gm Base/vial Injectable; Injection Maxipime Eq 2gm Base/vial Injectable; Injection Maxipime Eq 500mg Base/vial Injectable; Injection Suprax 100mg/5ml For Suspension; Oral Suprax 100mg/5ml Suspension; Oral Suprax 200mg **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Tablet; Oral NewDrugInformation |